Capsaicin and Cancer: Overview

Capsaicin, the active component in chili peppers, is responsible for their spiciness. Chemically, it belongs to the class of vanilloid compounds and has unique biological activity. Its molecular structure includes a long-chain fatty acid and a benzene ring, with the formula C18H27NO3. Capsaicin is lipophilic and chemically stable, retaining its activity even at high temperatures. It is primarily found in the fruit of chili peppers, especially in the seeds and inner membranes, and is secreted by gland cells in the plant. Capsaicin serves as a defensive compound for the chili plant, protecting it from herbivores in nature by deterring consumption.

Figure 1. Chemical Structure of Capsaicin
(Source: Bode AM, et al. 2011)

Biologically, capsaicin binds to the transient receptor potential vanilloid 1 (TRPV1), inducing calcium influx and triggering a range of physiological and pathological responses. This mechanism not only gives capsaicin its spicy flavor but also imparts potential pharmacological effects. In addition to its role in pain perception and inflammation regulation, recent research has focused on capsaicin's relationship with cancer, particularly its dual role in cancer therapy, where it can both fight cancer and promote it under specific conditions.

Capsaicin and TRPV1 Interaction

TRPV1 is the primary target for capsaicin. This receptor is present in sensory neurons and plays a key role in detecting heat, pain, and inflammation. Normally, capsaicin binds to TRPV1, causing a physiological response known as depolarization, which allows neurons to transmit pain signals. However, TRPV1 is not only limited to neurons but is also expressed in many cancer cells, where it influences various functions related to cancer progression.

Studies indicate that capsaicin activates TRPV1, leading to increased intracellular calcium, which triggers apoptosis (programmed cell death). The excessive calcium influx damages the mitochondria and generates reactive oxygen species (ROS), inducing oxidative stress, which eventually leads to cell death. ROS can degrade the DNA, proteins, and lipids in cancer cells, promoting their apoptosis. This mechanism allows capsaicin, at low doses, to effectively suppress cancer cell growth and even initiate their death.

Moreover, capsaicin can inhibit key cancer signaling pathways, such as NF-κB and PI3K/Akt, which are crucial for tumor growth and metastasis. NF-κB is a pathway associated with inflammation and cell survival, often linked to cancer cells' resistance to apoptosis. Capsaicin blocks NF-κB signaling, weakening the cancer cells' anti-apoptotic defenses and making them more susceptible to chemotherapy and other cancer treatments.

Figure 2. Mechanism of Capsaicin-Induced Pain
 (Source: Fattori V, et al. 2016)

Capsaicin's Anticancer Effects

Despite its carcinogenic potential, capsaicin, when used in moderation, exhibits strong anticancer properties. Experimental studies show that capsaicin can inhibit the growth and metastasis of cancer cells through various mechanisms. In certain cancers, such as breast cancer, prostate cancer, and colorectal cancer, capsaicin effectively suppresses cell proliferation by activating ROS, modulating apoptotic pathways, and inhibiting PI3K/Akt signaling.

Capsaicin can also inhibit angiogenesis, the process of new blood vessel formation, which is essential for tumor growth. This effect is achieved by reducing the expression of vascular endothelial growth factor (VEGF), thus limiting the tumor's blood supply and nutrient intake, thereby curbing its spread.

Another interesting phenomenon is that capsaicin increases cancer cells' sensitivity to chemotherapy and radiation therapy, improving treatment efficacy. Capsaicin has been found to make cancer cells more sensitive to certain chemotherapeutic agents, especially in cases where drug resistance is a concern. By suppressing anti-apoptotic pathways such as Bcl-2 and Bcl-xL, capsaicin enhances the cytotoxic effects of chemotherapy drugs on cancer cells.

Capsaicin as an Adjuvant in Cancer Therapy

Capsaicin not only serves as a direct anticancer agent but also holds potential as an adjuvant in cancer therapy. Experimental studies demonstrate that capsaicin can enhance the efficacy of existing cancer treatments, such as chemotherapy and radiation therapy, when used in combination. By regulating apoptotic pathways, capsaicin makes cancer cells more responsive to chemotherapy and radiotherapy, increasing treatment success rates.

Additionally, capsaicin can inhibit cancer cell invasion and metastasis. In some animal models, capsaicin significantly reduced distant metastasis by affecting the migratory and invasive abilities of cancer cells. This effect is primarily achieved by inhibiting extracellular matrix degradation and regulating cell adhesion molecules.

As a natural compound, capsaicin exhibits complex and multifaceted biological activity. Its role in cancer is dual, as it can activate TRPV1 receptors and ROS production pathways to exert anticancer effects while also posing a risk of promoting cancer under high doses or specific conditions. Future research should further explore capsaicin's dose-dependent effects and its specific mechanisms in various cancer types. Additionally, integrating capsaicin with existing cancer treatments to enhance efficacy and minimize side effects is a key direction for future studies. Capsaicin holds promise as a potential cancer therapy with further investigation.

Capsaicin ELISA Kits

Capsaicin Antibodies

Capsaicin Antigens

TRPV1 ELISA Kits

TRPV1 Antibodies

TRPV1 Antigens